524-21766-43684
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 060 / CT
- Registered
- 2022-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-22
Dose 1 — Moderna
-
2021-05-20
Dose 2 — Moderna
-
2022-02-04
Registered in v-safe
-
2022-02-04
Dose 3 — Pfizer-BioNTech
- 2022-02-04
-
2022-02-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-02-06
- 2022-02-07
- 2022-02-10
- 2022-02-11
- 2022-02-18
- 2022-02-25
- 2022-03-06
- 2022-03-12
- 2022-03-18
-
2022-05-06
Survey response — 3 months, dose 3MedDRA: Cough, Ear infection, Nasal congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Ear infection, cough, congested noseMedDRA releases: 2024-11 · check-in free text available
- 2022-08-06
- 2023-02-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-22 | Moderna | No |
| 2 | 2021-05-20 | Moderna | No |
| 3 | 2022-02-04 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 3
Symptoms: Ear infection, cough, congested nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release